Estimaciones de analistas de Wall Street para Lipocine Inc. (LPCN): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 0.79 |
| EV / EBITDA | -1.23 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $428031 | $164990 | 0 | $16.1M | $500000 | -$2.9M | $11.2M | $2.0M |
| Coste de Ventas | 0 | 0 | 0 | $7.5M | 0 | $7.7M | $8.6M | $10.2M | 0 | $8.6M |
| Beneficio Bruto | 0 | 0 | $428031 | -$7.3M | 0 | $8.5M | -$8.1M | -$13.0M | $11.2M | -$6.6M |
| I+D | $8.1M | $11.0M | $6.5M | $7.5M | $9.7M | 0 | 0 | 0 | $7.4M | 0 |
| Generales y Administrativos | $10.4M | $10.2M | $5.3M | $5.6M | $8.2M | $5.3M | $4.1M | $4.9M | $5.0M | $3.8M |
| Gastos Operativos | $19.0M | $21.0M | $12.1M | $5.6M | $18.0M | $5.3M | $4.1M | $4.9M | $12.4M | $3.8M |
| Beneficio Operativo | -$18.5M | -$21.2M | -$11.3M | -$12.9M | -$18.0M | $3.1M | -$12.1M | -$17.9M | -$1.2M | -$10.4M |
| EBITDA | -$18.9M | -$21.2M | -$11.3M | -$12.2M | -$18.0M | -$430527 | -$10.7M | -$16.3M | $50139 | -$9.6M |
| Gastos por Intereses | 0 | 0 | 0 | $343254 | $386618 | $203292 | $27098 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$19.0M | -$21.0M | -$11.7M | -$13.0M | -$21.0M | -$634199 | -$10.8M | -$16.4M | $9033 | -$9.6M |
| Impuestos | $752 | $700 | $700 | $200 | $200 | $200 | $681 | $755 | $681 | $200 |
| Beneficio Neto | -$19.0M | -$21.0M | -$11.7M | -$13.0M | -$21.0M | -$634399 | -$10.8M | -$16.4M | $8352 | -$9.6M |
| BPA | $-17.66 | $-17.79 | $-9.35 | $-8.54 | $-6.46 | $-0.19 | $-2.15 | $-3.14 | $0.00 | $-1.77 |
| BPA Diluido | $-17.68 | $-17.85 | $-9.28 | $-8.54 | $-6.40 | $-0.12 | $-2.05 | $-3.14 | $-0.00 | $-1.69 |
| Acciones en Circulación (Diluidas) | $1.1M | $1.2M | $1.3M | $1.5M | $3.3M | $5.2M | $5.3M | $5.3M | $5.4M | $5.7M |
Precio
| Precio | $2.16 |
| Capitalización | $18M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADAP · ANL · BLRX · EDSA · ERNA · GOVX · LNAI
Explorar sector: Healthcare · Biotechnology
Más secciones de LPCN: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones